Oncotarget

Research Papers:

Long non-coding RNA HULC promotes tumor angiogenesis in liver cancer by up-regulating sphingosine kinase 1 (SPHK1)

Zhanping Lu _, Zelin Xiao, Fabao Liu, Ming Cui, Weiping Li, Zhe Yang, Jiong Li, Lihong Ye and Xiaodong Zhang

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2016; 7:241-254. https://doi.org/10.18632/oncotarget.6280

Metrics: PDF 5723 views  |   HTML 5591 views  |   ?  


Abstract

Zhanping Lu1, Zelin Xiao1, Fabao Liu2, Ming Cui1, Weiping Li1,3, Zhe Yang1, Jiong Li1, Lihong Ye2 and Xiaodong Zhang1

1 The State Key Laboratory of Medicinal Chemical Biology, Department of Cancer Research, College of Life Sciences, Nankai University, Tianjin, P.R. China

2 The State Key Laboratory of Medicinal Chemical Biology, Department of Biochemistry, College of Life Sciences, Nankai University, Tianjin, P.R. China

3 Department of Medical Science Laboratory, Fenyang College, Shanxi Medical University, Fenyang, Shanxi Provence, P.R. China

Correspondence to:

Xiaodong Zhang, email:

Lihong Ye, email:

Keywords: HULC, HCC, SPHK1, angiogenesis, E2F1, miR-107

Received: May 04, 2015 Accepted: October 08, 2015 Published: November 02, 2015

Abstract

Highly up-regulated in liver cancer (HULC) is a long non-coding RNA (lncRNA). We found that HULC up-regulated sphingosine kinase 1 (SPHK1), which is involved in tumor angiogenesis. Levels of HULC were positively correlated with levels of SPHK1 and its product, sphingosine-1-phosphate (S1P), in patients HCC samples. HULC increased SPHK1 in hepatoma cells. Chicken chorioallantoic membrane (CAM) assays revealed that si-SPHK1 remarkably blocked the HULC-enhanced angiogenesis. Mechanistically, HULC activated the promoter of SPHK1 in hepatoma cells through the transcription factor E2F1. Chromatin immunoprecipitation (ChIP) and electrophoretic mobility shift assay (EMSA) further showed that E2F1 was capable of binding to the E2F1 element in the SPHK1 promoter. HULC increased the expression of E2F1 in hepatoma cells and levels of HULC were positively correlated with those of E2F1 in HCC tissues. Intriguingly, HULC sequestered miR-107, which targeted E2F1 mRNA 3′UTR, by complementary base pairing. Functionally, si-SPHK1 remarkably abolished the HULC-enhanced tumor angiogenesis in vitro and in vivo. Taken together, we conclude that HULC promotes tumor angiogenesis in liver cancer through miR-107/E2F1/SPHK1 signaling. Our finding provides new insights into the mechanism of tumor angiogenesis.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 6280